In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
News|Articles|June 21, 2024
5 Key Sessions and Interviews at McKesson ideaShare 2024
Author(s)Kennedy Ferruggia, Associate Editor
Pharmacy Times will be at McKesson ideaShare 2024 Conference in New Orleans, Louisiana from June 23 to June 26, 2024.
Advertisement
Pharmacy Times will be covering the
Stay tuned on
- An interview with Niki Shah, Vice President of Impact Innovation and Activation at McKesson, who will be discussing initiatives to support health equity. She will discuss how McKesson is supporting community pharmacies in advancing health equity and improve access to care.
- An educational session about women in pharmacy and sharing the journey in pharmacy ownership from Shahida Choudhry, PharmD, owner of Palms Pharmacy in Tampa Florida. She will share her perspective on being a woman in pharmacy and her opinions on the importance of leadership, networking, ownership, and work-life balance.
- An interview with Nancy Lyons, BSPharm, MBA, CDCES, Vice President and Chief Pharmacy Officer of Health Mart, who will be discussing new advocacy initiatives. She will discuss issues community pharmacists should actively advocate for at state and national levels, along with new initiatives that will be announced at McKesson ideaShare.
- A session about impacting your community through community health workers presented by experts and industry advocates. The session will discover how certified pharmacy technicians trained as community health workers have the capacity to serve as public health advocates and promote health equity.
- An interview with Crystal Lennartz, PharmD, MBA, President of Health Mart and Health Mart Atlas, who will be discussing how Health Mart and Health Mart Atlas can support profitability. She will discuss how community pharmacies can balance providing quality care and maintaining a profitable pharmacy.
Follow Pharmacy Times for coverage of the conference on our website and on social media for the latest updates.
Advertisement
Related to this article
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
2
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
3
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5